Gas chromatography mass spectrometry is the confirmation step in workplace drug testing, and understanding why it exists explains most of what confuses people about results. The first test is fast, cheap and deliberately imprecise. The second is slow, expensive and specific. Neither is meant to be used without the other, and a result based on the first alone should never reach an employer.
Two tests doing two different jobs
The initial screen is an immunoassay: it uses antibodies to detect a class of compounds, it is quick and inexpensive, and it is designed to be sensitive rather than specific. That means it will flag specimens that turn out not to contain what was suspected, which is a deliberate design choice, because a screen that missed real positives would be worse than one that over-flags. Confirmation then does the opposite job. Gas chromatography separates the compounds in the specimen and mass spectrometry identifies each by its molecular signature, so it names the specific substance rather than a class.
Why the screen alone must never be reported
Immunoassay cross-reactivity is real: substances chemically similar to the target can trigger a non-negative screen. That is precisely why the federal testing procedure requires confirmation before any result is reported as positive, and why reputable non-regulated programmes follow the same practice. An employer that receives a positive based on a screen alone has received something that should not have been sent, and a programme that reports one has a defect that will be found the first time a result is challenged.
Where the Medical Review Officer sits
Confirmation establishes what is in the specimen, not whether being there is a problem. A confirmed positive for an opioid or a benzodiazepine is entirely consistent with a lawful prescription, which is why the confirmed result goes to a Medical Review Officer before the employer sees anything. The MRO contacts the donor, considers any medical explanation offered, and reports the result accordingly. Employers who buy broad panels without MRO capacity end up receiving medical information they neither need nor should hold.
What this means for buying and for timing
When comparing testing quotes, confirm that confirmatory testing and Medical Review Officer review are included rather than billed separately on non-negatives, because a headline price that covers only the screen is not comparable with one that covers the process. It is also the explanation for the timeline: a negative comes back in a day or two because it stops at the screen, and a non-negative takes several days more because both further steps happen.
Questions people ask about gcms testing
What is GC-MS in drug testing?
Gas chromatography mass spectrometry, the confirmation method that separates the compounds in a specimen and identifies each by molecular signature, naming the specific substance rather than a class.
Why is a second test needed?
Because the initial immunoassay screen is designed to be sensitive rather than specific and can flag chemically similar substances. Confirmation is required before any result may be reported as positive.
Can a screen alone be a positive result?
It should never be reported as one. The federal procedure requires confirmation first, and a programme that reports an unconfirmed screen has a defect that will be found the first time a result is challenged.
Does confirmation mean the employee is in breach?
No. It establishes what is in the specimen. Whether it is a problem is for the Medical Review Officer to determine with the donor, since a lawful prescription is the most common explanation on prescription analytes.